SAH Global: is a holding company founded in 2005 with a focus on developing highly specialized projects in healthcare. The company's slogan "Developing Mobile/Modular Diagnostic, Radiation Oncology (inc. Proton Therapy & Boron Neutron Capture Therapy) Centers" highlights its commitment to cutting-edge medical technologies. Led by Mr. Feroz Agad, an experienced entrepreneur, SAH Global targets investment projects based on their long-term growth prospects and potential impact on the community. SAH Global's current focus lies in developing world-class proton therapy centers in the MENA region, designed to provide advanced cancer treatment with a focus on patient comfort and support, particularly for children. The company also plans to offer training, education, research, and development services to further establish these centers as leading facilities for cancer treatment in the region and beyond. The company recently secured a Venture Round investment on 01 January 2022 from Bristol City Funds, signaling confidence from the investment community in SAH Global's vision. With headquarters in the United States, SAH Global is positioned to make a significant impact in the healthcare industry, offering innovative solutions for cancer treatment and care.
No recent news or press coverage available for SAH Global.